NCT04228107Completed
Treatment Phenotypes for Adolescents With Asthma
Source: ClinicalTrials.gov · Last updated 6 Nov 2025
Brief summary (registry, in English)
This study will evaluate how adolescents take their asthma medications using an electronic medication monitor.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 10 Jan 2020
- Start date
- 16 Nov 2020
- Primary completion date
- 14 Jul 2024
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Asthma
- NCT number
- NCT04228107
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 16 Nov 2020 to the primary completion date, 14 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking more than 3 asthma related medications
Other illness
- Other significant chronic lung disease (from problem list)
- Cystic fibrosis
- Chronic respiratory failure
- Tracheostomy status
- Intersititial lung disease
Other
- Significant developmental delay
- Primary language other than English, Spanish, Catalan, Dutch, French, German or Italian
- Healthcare providers will be recruited as well to participate in focus groups as part of specific aim 2.
Who the study is looking for
- Diagnosis of asthma On an inhaled controller and rescue medication for which a propeller health device is available
Criteria the registry did not label
- For adolescent participants:
Age in the registry: 12 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Childrens Hospital Colorado Coordinator of this site? Confirm its status | Aurora | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.